Navigation Links
cAMP DataFile: Homogenous Cyclic AMP detection using High Efficiency Fluorescence Polarization

A Sensitive, Robust, Homogenous, and Rapid Assay
Uses High Efficiency Fluorescence Polarization (HEFP) detection method
Detects pmol amounts of cAMP
Optimized for cell extract and enzyme preparations
Requires no separation or wash steps
Available in a kit and in bulk packaging


Introduction
Cyclic adenosine monophosphate (cAMP) is a second messenger involved in the transduction of extracellular signals. The signal is initiated by the binding of a ligand to a G-protein coupled receptor followed by a series of enzyme mediated steps leading to the activation of the enzyme adenylyl cyclase. Adenylyl cyclase converts ATP into cyclic AMP that in turn activates protein kinases. Protein kinase activity is correlated to the intracellular concentration of cyclic AMP. The level of cyclic AMP is reduced by phosphodiesterase. Assays that determine the activities of these cellular regulators are important tools for high-throughput screening laboratories.


Intended Use
The cAMP Assay Kit is designed to determine concentrations of cyclic AMP in solution. The sources of cyclic AMP analyte may either be in vitro enzyme preparations or cell extracts.


Principle of the Assay
The assay is an antibody-mediated competitive binding reaction with a High Efficiency Fluorescence Polarization (HEFP) read out. Cyclic AMP (analyte) from sample, calibrators, or controls competes with fluorescein-labeled cAMP (tracer) for a limited number of anti-cAMP antibodies. In the absence of analyte, a maximal amount of tracer will be bound to the antibody.

Addition of analyte competes with the tracer for the limited binding sites, so that the extent of polarization is inversely proportional to the concentration of analyte.

HEFP is a detection method that discriminates on th e basis of molecular size. The tracer-antibody complex rotates more slowly than free tracer so that the fluorescence appears polarized. Displacement of the tracer by the analyte from the antibody results in a decrease in polarization. Free tracer is small, spins rapidly relative to the fluorescence lifetime and thus emits light that is detected as having low polarization. HEFP does not require physical separation steps or wash steps.

The reagents have been optimized to provide a sensitive, robust and rapid homogeneous assay. Individual assays of cell lysates or of purified adenylyl cyclase will require optimization and validation based upon the requirements of the individual test systems.


Kit Contents
The kit contains anti-cAMP antibody (100X), tracer (fluorescein-labeled cAMP, 100X), calibrator cAMP (500 M) and HEFP Assay Buffer. When used as suggested, each kit provides sufficient reagents for 800 40-L assays.


Assay Conditions
Samples or calibrators containing cAMP are mixed with fluorescein-labeled tracer and anti-cAMP antibody in microplate wells and analyzed after 2 hours.

The kit is designed for standard 384-well microplates with a 40 L sample volume. It can be scaled down to an 8 L sample volume, with the same performance, using HE microplates in any instrument in the Criterion family.


Applications
Measurement of adenylyl cyclase activity1
Monitoring phosphodiesterase activity2


Assay Performance
Calibration curve: A calibration curve was performed in 384-well microplates with a final volume of 40 L. Background signals (buffer only or antibody only) were appropriately subtracted and net polarization calculated. The minimum detectable concentration was 0.1 pmol.


Measuring adenylyl cyclase activity: Cultured T-47D cells were treated for 15 min with either buffer (control), forskolin, isoproternol, or isoproterenol and propranolol. Formation of cAMP was determined with the cAMP Assay Kit. The assay was performed in 384-well microplates in a final volume of 40 L. Each treatment group was performed in triplicate.



Please contact your local Molecular Devices representative for price and delivery information.


Certain aspects of the technology and design of Molecular Devices products are protected under current or pending patents.


1 Chedeville, A. et al. FEBS Letters 319:171176 1993
2 Chan, S.C. and Hanifan, J.M. S. J. Clin. Med. 121:4451 1993


back to top


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. TKXtra DataFile: Homogenous tyrosine kinase detection using High Efficiency Fluorescence Polarization
2. Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system
3. Monitoring transfection efficiency by green fluorescent protein (GFP) detection with the Agilent 2100 bioanalyzer
4. Apoptosis detection by annexin V and active caspase-3 with the Agilent 2100 bioanalyzer
5. Sensitive detection of tumor cells in peripheral blood of carcinoma patients by a reverse transcription PCR method
6. Rapid detection of genomic duplications and deletions using the Agilent 2100 bioanalyzer
7. Mutation detection for the K- rasand P16 genes
8. Multiplex protein detection with the ECL Plex fluorescent Western blotting system using the Ettan DIGE Imager
9. The combination of monolithic columns and modern HPLC/MS/MS instrumentation for high chromatographic throughput and sensitive detection of beta-agonists
10. Front-face detection for high-concentrate, opaque or solid sample
11. Outstanding transfection rates using the Multiporator
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... New York , November 30, 2016 ... consolidated as a few players hold a dominant share ... Group, Charles River Laboratories International, Inc., and Merck KGaA, ... market in 2015. Transparency Market Research observes that these ... are focused on development products that are do not ...
(Date:11/30/2016)... RATON, Fla. , Nov. 30, 2016 ... biotherapeutic products, is pleased to announce the addition of ... Avenue Kearney, Nebraska . The 15,200 ... business on November 29th, 2016 and brings the total ... Ileana Carlisle , BPC,s Chief Executive ...
(Date:11/30/2016)... /PRNewswire/ -  Equicare Health Inc ., the leading supplier ... one of the top 100 companies in the 2016 ... distinguishes the top digital health companies across the globe. ... this year continually upgrading our product with the ongoing ... team," says Len Grenier , CEO of Equicare ...
(Date:11/30/2016)... SAN DIEGO and BEIJING ... Ltd., a leading commercial provider of genomic services and ... expertise, announced today that it has completed a USD ... China Merchants Bank Co., Ltd.,s CMB International Capital Management ... SDIC Innovation Investment Management Co., Ltd. ("SDIC Innovation") and ...
Breaking Biology Technology:
(Date:11/29/2016)... 29, 2016 BioDirection, a privately held medical ... the objective detection of concussion and other traumatic brain ... completed a meeting with the U.S. Food and Drug ... Pre-Submission Package. During the meeting company representatives reviewed plans ... precursor to commencement of a planned pilot trial. ...
(Date:11/28/2016)... "The biometric system market ... The biometric system market is in the growth stage ... future. The biometric system market is expected to be ... CAGR of 16.79% between 2016 and 2022. Government initiative ... in smartphones, rising use of biometric technology in financial ...
(Date:11/22/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the company ... Life Sciences Awards as "Most Outstanding in eClinical ... year of recognition and growth for MedNet, which has ... iMedNet ™ , MedNet,s flagship ...
Breaking Biology News(10 mins):